Specifically, the LS means for SBP, serum creatinine levels, and glomerular sclerosis index in the ESX + Dapa group were significantly lower than those in the Ald-treated group and approached levels observed in the control group. The gene discussed is ABCD1; the disease is Glomerular sclerosis.